These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 33443384)

  • 61. The emergence of a new cytokine storm during the COVID-19 pandemic: Multisystem inflammatory syndrome in children.
    Yang MC; Tsai CC; Su YT; Wu JR
    Kaohsiung J Med Sci; 2021 Mar; 37(3):255-256. PubMed ID: 33400372
    [No Abstract]   [Full Text] [Related]  

  • 62. [The neurology of COVID-19].
    Cuevas-García C; Calderón-Vallejo A; Berrón-Ruiz L
    Rev Alerg Mex; 2020; 67(4):338-349. PubMed ID: 33631902
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synergy Between Cytokines and Risk Factors in the Cytokine Storm of COVID-19: Does Ongoing Use of Cytokine Inhibitors Have a Protective Effect?
    Miossec P
    Arthritis Rheumatol; 2020 Dec; 72(12):1963-1966. PubMed ID: 32725790
    [No Abstract]   [Full Text] [Related]  

  • 64. What Is a Cytokine Storm and Should It Matter to Me?
    Simkin J; Strange T; Leblanc N; Rivera JC
    J Am Acad Orthop Surg; 2021 Apr; 29(7):297-299. PubMed ID: 33443384
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Interleukin-6, CXCL10 and Infiltrating Macrophages in COVID-19-Related Cytokine Storm: Not One for All But All for One!
    Coperchini F; Chiovato L; Rotondi M
    Front Immunol; 2021; 12():668507. PubMed ID: 33981314
    [TBL] [Abstract][Full Text] [Related]  

  • 66. The cytokine storm in COVID-19: Further advances in our understanding the role of specific chemokines involved.
    Coperchini F; Chiovato L; Ricci G; Croce L; Magri F; Rotondi M
    Cytokine Growth Factor Rev; 2021 Apr; 58():82-91. PubMed ID: 33573850
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Emerging nanomaterials applied for tackling the COVID-19 cytokine storm.
    Yang X; You J; Wei Y; Li H; Gao L; Guo Q; Huang Y; Gong C; Yi C
    J Mater Chem B; 2021 Oct; 9(39):8185-8201. PubMed ID: 34528037
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets.
    Kumar V
    Int Immunopharmacol; 2020 Dec; 89(Pt B):107087. PubMed ID: 33075714
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Cytokine Storm as a Cellular Response to dsDNA Breaks: A New Proposal.
    Shabrish S; Mittra I
    Front Immunol; 2021; 12():622738. PubMed ID: 33597956
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytokine Storm.
    Fajgenbaum DC; June CH
    N Engl J Med; 2020 Dec; 383(23):2255-2273. PubMed ID: 33264547
    [No Abstract]   [Full Text] [Related]  

  • 71. Age-related mitochondrial dysfunction as a key factor in COVID-19 disease.
    Moreno Fernández-Ayala DJ; Navas P; López-Lluch G
    Exp Gerontol; 2020 Dec; 142():111147. PubMed ID: 33171276
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 73.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.